Literature DB >> 17556066

Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells.

Yun Ren1, Xishi Liu, Duan Ma, Youji Feng, Nanbert Zhong.   

Abstract

Progesterone plays an important role in the regulation of normal endometrium function by binding to progesterone receptor (PR). In endometrial cancer, however, PR is always down-regulated. Previous reports showed that methylation in the promoter region of the PR gene may be responsible for PRB isoform repression. However, the CpG islands in the exon region of the PR gene are much richer and longer than in the promoter region. We hypothesize that methylation in the exon region may also take part in the down-regulation of the PR gene. The methylation status of the first exon of the PR gene in endometrial cell cultures was investigated. Aberrant methylation patterns were observed in the first exon of PR gene, and the methylation density is correlated with the differentiation of different types of endometrial cancer cells. DNA methyltransferase (DNMT) and histone deacetylase inhibitor 5-aza-2'-deoxycytidine (ADC), as well as trichostatin A (TSA), which reverses PR gene expression, were also studied. A combination of ADC and TSA resulted in synergistic effects in inducing PR expression, down-regulation of DNMT1 and DNMT3A, and could also have antigrowth effect on endometrial cancer cells by inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556066     DOI: 10.1016/j.cancergencyto.2007.02.002

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  21 in total

1.  Endometrial cancer.

Authors:  Kimberly K Leslie; Kristina W Thiel; Michael J Goodheart; Koen De Geest; Yichen Jia; Shujie Yang
Journal:  Obstet Gynecol Clin North Am       Date:  2012-06       Impact factor: 2.844

2.  Epigenetic modification restores functional PR expression in endometrial cancer cells.

Authors:  Shujie Yang; Xue Xiao; Yichen Jia; Xiaoyue Liu; Yuping Zhang; Xinjun Wang; Christopher J Winters; Eric J Devor; Xiangbing Meng; Kristina W Thiel; Kimberly K Leslie
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

Review 4.  DNA methylation in endometrial cancer.

Authors:  Meng Hua Tao; Jo L Freudenheim
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

Review 5.  Progesterone: the ultimate endometrial tumor suppressor.

Authors:  Shujie Yang; Kristina W Thiel; Kimberly K Leslie
Journal:  Trends Endocrinol Metab       Date:  2011-02-25       Impact factor: 12.015

6.  The reproductive phenotype of mice null for transcription factor Krüppel-like factor 13 suggests compensatory function of family member Krüppel-like factor 9 in the peri-implantation uterus.

Authors:  Melissa E Heard; John Mark P Pabona; Carol Clayberger; Alan M Krensky; Frank A Simmen; Rosalia C M Simmen
Journal:  Biol Reprod       Date:  2012-11-16       Impact factor: 4.285

7.  Krüppel-like factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: implications for the pathogenesis of endometriosis.

Authors:  John Mark P Pabona; Frank A Simmen; Mikhail A Nikiforov; DaZhong Zhuang; Kartik Shankar; Michael C Velarde; Zara Zelenko; Linda C Giudice; Rosalia C M Simmen
Journal:  J Clin Endocrinol Metab       Date:  2012-01-18       Impact factor: 5.958

8.  Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells.

Authors:  Nicolás Bellora; François Le Dily; Alejandro La Greca; Rodrigo Jara; Ana Silvina Nacht; Javier Quilez Oliete; José Luis Villanueva; Enrique Vidal; Gabriela Merino; Cristóbal Fresno; Inti Tarifa Reischle; Griselda Vallejo; Guillermo Vicent; Elmer Fernández; Miguel Beato; Patricia Saragüeta
Journal:  Elife       Date:  2022-01-12       Impact factor: 8.140

9.  Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer.

Authors:  He-Ling Wang; Han Bai; Yan Li; Jun Sun; Xue-Qing Wang
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 10.  Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.

Authors:  Eric Badia; Joan Oliva; Patrick Balaguer; Vincent Cavaillès
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.